| -0.03 / -0.38%|
The 8 analysts offering 12-month price forecasts for Raptor Pharmaceutical Corp have a median target of 11.50, with a high estimate of 17.00 and a low estimate of 7.00. The median estimate represents a +47.44% increase from the last price of 7.80.
The current consensus among 9 polled investment analysts is to Buy stock in Raptor Pharmaceutical Corp. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.